Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 1, 2008, Pages 380-388

  Thi, Thanh Huong Hoang ^a   Danède, Florence ^a   Descamps, Marc ^a   Flament, Marie Pierre ^a  

^a UNIV LILLE   (France)

Author keywords

Adhesion; Aerodynamic behaviour; Dry powder inhaler; Physicochemical properties; Spray drying; Terbutaline sulphate

Indexed keywords

INHALAC 120; INHALAC 230; LACTOHALE 100; LACTOHALE 200; LACTOSE; TERBUTALINE SULFATE; UNCLASSIFIED DRUG;

ADHESION; ARTICLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRY POWDER; DYNAMICS; IN VITRO STUDY; INHALER; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY DIFFRACTION;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DESICCATION; DRUG CARRIERS; LACTOSE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TERBUTALINE; TISSUE ADHESIONS;

EID: 50149111529     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.04.002     Document Type: Article

References (21)

1. Hersey J.A. Ordered mixing: a new concept in powder mixing practice. Powder Technol. 11 (1975) 41-44
2. Bell J. Dry powder inhalation technology. Pharm. Manufact. Int. (1994) 179-182
3. Prime D., Atkins P.J., Slater A., and Sumby B. Review of dry powder inhalers. Adv. Drug Deliv. Rev. 26 (1997) 51-58
4. Davies P.J., Hanlon G.W., and Molyneux A.J. An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified "Kirk Lung". J. Pharm. Pharmacol. 28 (1976) 908-911
5. Steckel H., Pichert L., and Müller B.W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 57 (2004) 507-512
6. Bosquillon C., Rouxhet P.G., Ahimou F., Simon D., Culot C., Préat V., and Vanbever R. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control. Release 99 (2004) 357-367
7. Chougule M.B., padhi B.K., Jinturkar K.A., and Misra A. Development of dry powder inhalers. Recent Patents Drug Deliv. Formul. 1 (2007) 11-21
8. Rabbani N.R., and Seville P.C. The influence of formulation components on the aerosolisation properties of spray-dried powders. J. Control. Release 110 (2005) 130-140
9. Vidgrén M.T., Vidgrén P.A., and Paronen T.P. Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate. Int. J. Pharm. 35 (1987) 139-144
10. Chawla A., Taylor K.M.G., Newton J.M., and Johnson M.C.R. Production of spray dried salbutamol sulphate for use in dry powder aerosol formulation. Int. J. Pharm. 108 (1994) 233-240
11. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., and Edwards D.A. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16 (1999) 431-437
12. Bosquillon C., Lombry C., Preat V., and Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolisation performance. J. Control. Release 70 (2001) 329-339
13. Najafabadi A., Gilani K., Barghi M., and Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. Int. J. Pharm. 285 (2004) 97-108
14. Bosquillon C., Preat V., and Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualisation of its local fate in rats. J. Control. Release 96 (2004) 233-244
15. Corrigan D.O., Corrigan O.I., and Healy A.M. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Int. J. Pharm. 322 (2006) 22-30
16. Zeng X.M., Martin G.P., Marriott C., and Pritchard J. The influence of carrier morphology on drug delivery by dry powder inhalers. Int. J. Pharm. 176 (2000) 93-106
17. Corrigan O.I., and Holohan E.M. Amorphous spray dried hydroflumethiazide-polyvinyl pyrrolidone systems. J. Pharm. Pharmacol. 36 (1984) 217-221
18. Corrigan O.I., Holohan E.M., and Sabra K. Amorphous forms of diuretics prepared by spray drying. Int. J. Pharm. 18 (1984) 195-200
19. Sebhatu T., Angberg M., and Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int. J. Pharm. 104 (1993) 135-144
20. US Pharmacopeia, (905) Uniformity of dosage units: content uniformity (2004) 2396-2397.
21. Flament M.P., Leterme P., and Gayot A. The influence of carrier roughness on adhesion content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int. J. Pharm. 275 (2004) 201-209